Nutraceutical Corp is 114
This article was originally published in The Tan Sheet
Park City, Utah-based firm was rated 114 of 200 in Forbes Best Small Companies in America for 2003, Nutraceutical Corp announces. Supplement marketer notes the honor was bestowed for second consecutive year...
You may also be interested in...
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Coherus BioSciences is aiming to translate the success of its comprehensive biosimilar pegfilgrastim strategy to adalimumab, with plans to capture at least 10% of the US market upon formation in 2023. Management summarized the firm’s expectations during the company’s fourth-quarter earnings call, which revealed a downturn in pegfilgrastim sales and profitability.